Literature DB >> 15467714

Expression profile of tuberin and some potential tumorigenic factors in 60 patients with uterine leiomyomata.

Jianjun Wei1, Luis Chiriboga, Masashi Mizuguchi, Herman Yee, Khush Mittal.   

Abstract

Human uterine leiomyomata are the most common tumors in women of reproductive age. The pathogenesis of leiomyomata remains unknown. An animal model of Eker rats with deleted tuberous sclerosis complex gene 2 (tuberin) shows increased incidence of leiomyomata. The role of tuberin in human leiomyomata is unknown. In this study, we designed a tissue microarray with tissue cores of leiomyomata and the matched myometrium from 60 hysterectomy specimens. We examined the expression of tuberin and tuberous sclerosis complex gene 1 product hamartin, proteins of the insulin-signaling pathway, steroid receptors and some of their cofactors, and human mobility group gene A2 by immunohistochemistry. We found that nearly half of the cases displayed either reduction or loss of tuberin in leiomyomata compared with matched normal myometrium. No change of hamartin was noted. Furthermore, a significant reduction of glucocorticoid receptor was found in leiomyomata with reduced tuberin. The proteins insulin like growth factor 1, insulin-like growth factor receptor beta, AKT kinase, and phosphatidylinositol 3-kinase were upregulated. Nearly half of leiomyomata show upregulation of human mobility group gene A2, along with the steroid receptor cofactors. Our findings suggest that there are two broad groups of uterine leiomyomata. One group is associated with an alteration of tuberin and glucocorticoid receptor. The other group is associated with upregulation of human mobility group gene A2 and steroid receptor cofactors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15467714     DOI: 10.1038/modpathol.3800283

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  13 in total

1.  1,25-dihydroxyvitamin D3 regulates expression of sex steroid receptors in human uterine fibroid cells.

Authors:  Ayman Al-Hendy; Michael P Diamond; Ahmed El-Sohemy; Sunil K Halder
Journal:  J Clin Endocrinol Metab       Date:  2015-01-27       Impact factor: 5.958

2.  MK-2206, an AKT inhibitor, promotes caspase-independent cell death and inhibits leiomyoma growth.

Authors:  Elizabeth C Sefton; Wenan Qiang; Vanida Serna; Takeshi Kurita; Jian-Jun Wei; Debabrata Chakravarti; J Julie Kim
Journal:  Endocrinology       Date:  2013-09-03       Impact factor: 4.736

3.  Dietary glycemic index and load in relation to risk of uterine leiomyomata in the Black Women's Health Study.

Authors:  Rose G Radin; Julie R Palmer; Lynn Rosenberg; Shiriki K Kumanyika; Lauren A Wise
Journal:  Am J Clin Nutr       Date:  2010-03-03       Impact factor: 7.045

Review 4.  Endocrine-disrupting chemicals and uterine fibroids.

Authors:  Tiffany A Katz; Qiwei Yang; Lindsey S Treviño; Cheryl Lyn Walker; Ayman Al-Hendy
Journal:  Fertil Steril       Date:  2016-08-21       Impact factor: 7.329

5.  Profiling and functional analyses of microRNAs and their target gene products in human uterine leiomyomas.

Authors:  Jiri Zavadil; Huihui Ye; Zhaojian Liu; JingJing Wu; Peng Lee; Eva Hernando; Patricia Soteropoulos; Gokce A Toruner; Jian-Jun Wei
Journal:  PLoS One       Date:  2010-08-24       Impact factor: 3.240

6.  Differential endothelin receptor expression and function in rat myometrial cells and leiomyoma ELT3 cells.

Authors:  Marie-Noëlle Raymond; Philippe Robin; Federica De Zen; Ginette Vilain; Zahra Tanfin
Journal:  Endocrinology       Date:  2009-07-23       Impact factor: 4.736

7.  Constitutive activation of Beta-catenin in uterine stroma and smooth muscle leads to the development of mesenchymal tumors in mice.

Authors:  Pradeep S Tanwar; Ho-Joon Lee; LiHua Zhang; Lawrence R Zukerberg; Makoto M Taketo; Bo R Rueda; Jose M Teixeira
Journal:  Biol Reprod       Date:  2009-04-29       Impact factor: 4.285

8.  Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas.

Authors:  Linda Yu; Katrin Saile; Carol D Swartz; Hong He; Xiaolin Zheng; Grace E Kissling; Xudong Di; Shantelle Lucas; Stanley J Robboy; Darlene Dixon
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

9.  Uterine leiomyomata in relation to insulin-like growth factor-I, insulin, and diabetes.

Authors:  Donna D Baird; Greg Travlos; Ralph Wilson; David B Dunson; Michael C Hill; Aimee A D'Aloisio; Stephanie J London; Joel M Schectman
Journal:  Epidemiology       Date:  2009-07       Impact factor: 4.822

10.  Epigenomic tensor predicts disease subtypes and reveals constrained tumor evolution.

Authors:  Jacob R Leistico; Priyanka Saini; Christopher R Futtner; Miroslav Hejna; Yasuhiro Omura; Pritin N Soni; Poorva Sandlesh; Magdy Milad; Jian-Jun Wei; Serdar Bulun; J Brandon Parker; Grant D Barish; Jun S Song; Debabrata Chakravarti
Journal:  Cell Rep       Date:  2021-03-30       Impact factor: 9.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.